Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Scholar Rock Holding Corp (SRRK)
NASDAQ:SRRK
Scholar Rock Holding (SRRK) Stock Price & Analysis
149 Followers
SRRK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.33 - $13.00
Previous Close$6.35
Volume196.30K
Average Volume (3M)236.51K
Market Cap
$344.75M
Enterprise Value$136.96M
Total Cash (Recent Filing)$275.28M
Total Debt (Recent Filing)$67.50M
Price to Earnings (P/E)-2.2
Beta1.48
Next Earnings
Nov 13, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.86
Shares Outstanding54,291,331
10 Day Avg. Volume218,547
30 Day Avg. Volume236,510
Standard Deviation0.27
R-Squared0.02
Alpha0.00835
Financial Highlights & Ratios
Price to Book (P/B)1.72
Price to Sales (P/S)492.50
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-195.66
Enterprise Value/Gross Profit4.13
Enterprise Value/Ebitda-0.81
Forecast
1Y Price Target
$28.00Price Target Upside340.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Scholar Rock Holding News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRRK FAQ
What was Scholar Rock Holding Corp’s price range in the past 12 months?
Scholar Rock Holding Corp lowest stock price was $4.33 and its highest was $13.00 in the past 12 months.
What is Scholar Rock Holding Corp’s market cap?
Currently, no data Available
When is Scholar Rock Holding Corp’s upcoming earnings report date?
Scholar Rock Holding Corp’s upcoming earnings report date is Nov 13, 2023 which is in 169 days.
How were Scholar Rock Holding Corp’s earnings last quarter?
Scholar Rock Holding Corp released its earnings results on May 09, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.522 by $0.032.
Is Scholar Rock Holding Corp overvalued?
According to Wall Street analysts Scholar Rock Holding Corp’s price is currently Undervalued.
Does Scholar Rock Holding Corp pay dividends?
Scholar Rock Holding Corp does not currently pay dividends.
What is Scholar Rock Holding Corp’s EPS estimate?
Scholar Rock Holding Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scholar Rock Holding Corp have?
Scholar Rock Holding Corp has 54,291,332 shares outstanding.
What happened to Scholar Rock Holding Corp’s price movement after its last earnings report?
Scholar Rock Holding Corp reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.522. Following the earnings report the stock price went up 5.978%.
Which hedge fund is a major shareholder of Scholar Rock Holding Corp?
Among the largest hedge funds holding Scholar Rock Holding Corp’s share is Caxton Associates LP. It holds Scholar Rock Holding Corp’s shares valued at N/A.
---
Scholar Rock Holding Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$28.00 (340.94% Upside)
$28.00 (340.94% Upside)
Blogger Sentiment
Bullish
SRRK Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 30.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $202.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.68%
12-Months-Change
Fundamentals
Return on Equity
-82.97%
Trailing 12-Months
Asset Growth
18.33%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Scholar Rock Holding Corp
Scholar Rock Holding Corp. is a biopharmaceutical company, which engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding SRRK
iShares Biotechnology ETF
$1.76M
iShares NASDAQ US Biotechnology UCITS ETF
$175.61K
Fidelity MSCI Health Care Index ETF
$140.49K
Invesco Nasdaq Biotechnology ETF
$6.34K
Dimensional U.S. Equity ETF
$5.19K
Up to five ETFs with an Outperform Smart Score that hold SRRK. The ETFs are listed according to market value of SRRK within the ETF
---
Biohaven Ltd.
―
Atara Biotherapeutics
―
Nkarta
―
Monte Rosa Therapeutics
―
Aura Biosciences Inc
―
---